3 Growth Stocks For October 2026
Interest rates are rising again as the Federal Reserve works to contain inflation, which is putting pressure on companies that rely heavily on cheap debt. That backdrop makes financially sound businesses with strong expected earnings growth especially interesting. This article looks at three such stocks that analysts expect to grow profits quickly while keeping balance sheets in check, helping you focus on quality growth rather than just the next hot story.
The stocks highlighted below are just a small sample, and the full screen surfaced 1,568 more companies with equally compelling growth and balance sheet stories that are not covered here.
If you want to go straight to the source, use the Healthy high growth potential screener to identify, filter, and analyze healthy high growth opportunities that best match your own risk and return preferences.
Amylyx Pharmaceuticals (AMLX)
Overview: Amylyx Pharmaceuticals is a clinical-stage biotech developing treatments for rare endocrine and neurodegenerative diseases, anchored by late-stage AMX0114 and AMX0035 programs.
Market Cap: US$3.5b
Amylyx Pharmaceuticals fits the Healthy high growth potential theme because its late-stage avexitide program and broader pipeline tie future earnings directly to a handful of upcoming clinical and regulatory milestones.
"Advancement of avexitide as a potential first approved therapy for post bariatric hypoglycemia, supported by five prior PBH trials and a fully recruited pivotal Phase III LUCIDITY study with top line data expected in Q3 2026, could open a new rare disease revenue stream if outcomes support approval and reimbursement."
What happens to Amylyx’s growth story hinges on how one unresolved pressure shapes future pricing power and real-world treatment uptake.
That pressure point is exactly where the story gets interesting, and the full narrative for Amylyx Pharmaceuticals shows how pricing power, uptake scenarios, and risk could be decoupling expectations.
Micron Technology (MU)
Overview: Micron Technology supplies memory and storage chips like DRAM, high-bandwidth memory, and data-center SSDs that power cloud, AI, and other electronics worldwide.
Market Cap: US$1.21t
Micron Technology fits the Healthy high growth potential theme because its cloud and data-center memory products are closely linked to rising AI and hyperscale demand. The rest of the portfolio adds breadth across mobile, PCs, cars, and industrial equipment.
"Every AI accelerator needs high-bandwidth memory. Every inference system needs DRAM capacity. Every data center needs SSDs."
Micron’s earnings power now depends on how supply and pricing pressure shape margins across this AI-driven memory cycle.
How that pricing power story plays out is where it really gets interesting, and the full narrative for Micron Technology unpacks how supply swings, AI demand, and margins could be decoupling expectations.
Space Exploration Technologies (SPCX)
Overview: Space Exploration Technologies operates rockets, Starlink satellite broadband, and an AI platform that together provide space access, global connectivity, and compute services.
Operations: Space Exploration Technologies generates about US$13.9b from Connectivity, US$5.1b from AI, and US$4.1b from Space operations.
Market Cap: US$2,157.5b
Space Exploration Technologies fits the Healthy high growth potential theme because Starlink’s subscription broadband and AI infrastructure contracts offer rapidly scaling, recurring cash flows that could meaningfully shift earnings over the next few years.
"Starlink satellite internet is currently the main driver of revenue and is the only division reporting an operating profit."
The outlook for Space Exploration Technologies’ growth story largely comes down to how one capital intensive bet reshapes future margins and cash generation.
That capital bet could reshape the whole earnings mix, and the full narrative for Space Exploration Technologies lays out how Space Exploration Technologies might turn today’s heavy lifting into accelerating long term cash generation.
Seeking Fresh Alternatives Before They Fly
Momentum can shift quickly, and the strongest breakout candidates rarely stay under the radar for long. Scan fresh ideas before the crowd catches on and valuations adjust, then decide whether they fit your strategy.
- Spot cash rich compounders early by running the list of solid balance sheet and fundamentals (25 results) that highlights financially resilient companies before stronger balance sheets are fully reflected in the market.
- Identify income opportunities by scanning the 7 dividend fortresses that surfaces high yield payers where payouts and balance sheet strength currently align.
- Review potential AI-oriented companies by checking the 37 profitable AI stocks that aren't just burning cash focusing on cash generating operators where expectations may not yet be widely discussed.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com